spacer
home > ebr > Summer 2013
PUBLICATIONS

European Biopharmaceutical Review

ebr
Summer 2013

   
Text
PDF
bullet
STRATEGY AND FINANCE
New Finance Models

A Common Cause

Oliver Timmis at the AKU Society investigates how collaboration between medical research charities and patient organisations could fund vital studies.
 
view
download pdf
Science and Innovation
Phage Prevention

Detection Validation

The presence of bacteriophages in fermentation and the facility environment needs to be constantly monitored by microbiologists. But when this is not possible, what other options are there? Marcin Los at Phage Consultants sheds light on this growing problem.
 
view
download pdf
Rediscovery

More for Less

The advantages of drug repurposing are vast, however the development costs involved risk stifling this innovation, argues Bruce Bloom at Cures Within Reach.
 
view
download pdf
Regulation and Finance

Tailored Medicine

With the help of a revised European Directive, bespoke treatments are entering the oncology industry and are being presented as safer and more effective, as Vincent O’Neill and Debasish Roychowdhury at Sanofi Oncology demonstrate.
 
view
download pdf
Organism Development

All Systems Go

A new discipline has risen in recent years: systems biology. José Manuel Mas and Albert Pujol Torras at Anaxomics describe the two main strategies that are used in this scheme – the topological and the functional.
 
view
download pdf
bullet
BioResearch and Innovation
Genotoxicity Screening

Early Identification

Steve Beasley at Gentronix assesses the need for the early screening of genetic toxicity to minimise late-stage attrition costs and improve compound quality.
 
view
download pdf
BioDiscovery
Drug Development

Tunable Half-Life Technology

Mark Perkins at Novozymes Biopharma analyses the challenges of biological drugs’ short half-lives, and how extension technology could resolve this problem.
 
view
download pdf
bullet
Drug Discovery
Tailoring Treatments

Critical Overhaul

Rick Morrison at Comprehend Systems demonstrates how the combination of rising patient demands and pioneering new technology could be the solution to bespoke medicine.
 
view
download pdf
Repurposing

Intelligent Approaches

In order to develop the drug discovery market and find indications for orphan conditions, alternative methods have to be implemented.Robert Scoffin and Alan Rothaul at Re-Pharm investigate the potential of drug repurposing or reprofiling to address this issue.
 
view
download pdf
Anti-Infective Drugs

The PK/PD Complex

In revealing the specific distinctions of a compound, pharmacokinetic and pharmacodynamic properties are being used and are becoming an increasing area of interest, suggests medical author Deborah Erickson.
 
view
download pdf
Cancer Therapy

The T Cell Promise

The evolution of the cancer therapy field is progressing through the help of T cells, which may eventually prove able to eradicate tumours. Namir J Hassan and Joanne Oates at Immunocore discuss the potential of this strategy.
 
view
download pdf
bullet
BioRegional
Bioregional

Innovative India

Andrew Barrett at Cambridge Consultants illustrates how Indian pharmaceutical companies are planning to create super-generics, and how they could potentially become a major force in the connected health market.
 
view
download pdf
bullet
INTERVIEW
Industry Interview

Insider Information

Jon Weisberg of SAFE-BioPharma reveals his career motivation and looks forward to the future of the biopharma sector.
 
view
download pdf
bullet
RESEARCH AND DEVELOPMENT
Oncology Drugs

Purposeful Reprofiling

A burgeoning trend in cancer prevention has been the treatment of patients with drugs that have already been approved in therapeutic areas other than oncology, as Rachel Meighan-Mantha at Citeline explains.


 
view
download pdf
Vaccines

Prevention is Better than Cure

Emanuela Signori at CNR-IFT and Vito Michele Fazio at UCBM discuss how recent research into the immune system biology has led to new strategies within the DNA vaccination area.

 
view
download pdf
Gene Therapy

Great Promise

Introducing therapeutic genetic material into a disease cell to correct phentotypes is becoming a popular concept in curing monogenic conditions. Bobby Gaspar and Christine Rivat at UCL talk us through this model.
 
view
download pdf
Protein Drugs

The Sugar is the Key

Taegen Clary at Agilent explains how analytical methods can aid the manufacturing process of protein biologics, which are especially important at a time of increasing patent expirations.
 
view
download pdf
Detection Techniques

Identifying Impurities

Process-related contamination from host cells is a relentless problem that needs to be addressed. Andrew Kenyon at RSSL assesses the situation and suggests alternative methods to tackle this issue.
 
view
download pdf
   
spacer
Edited by
Dr Deborah O'Neil,
Chief Executive and Scientific Officer,
NovaBiotics Ltd
Published quarterly in
January, April,
July, and October

News and Press Releases

Digital Manufacturing is a top priority for Life Sciences according to Zenith survey

Zenith Technologies, a world leader in delivering GMP manufacturing software solutions to the life sciences industry, recently conducted an industry survey that suggests the digital manufacturing is a top priority.
More info >>

White Papers

eSource: Reducing Site Workload for Better, Faster, Safer Clinical Trials

Clinical Ink

Unlike traditional electronic data capture (EDC), SureSource, Clinical Ink’s eSource platform, was designed from the beginning to minimize clinical trial complexity for site users. A Site Impact Survey provides scientific evidence regarding the impact of SureSource from 517 site users. Results confirm it significantly reduces workload, lessens queries, and improves data quality compared to paper and EDC. In this white paper, we quantitatively evaluate survey outcomes, provide qualitative feedback from survey respondents, and highlight the observed benefits of SureSource for transforming clinical research.
More info >>

Industry Events

PDA Parenteral Packaging 2019

19-20 March 2019, Hilton Molino Stucky, Venice, Italy

PDA Europe’s Conference has become a must-attend event for all professionals in the Parenteral Packaging arena. Join us in Venice in March 2019 to continue and further deepen scientific advancements and our ongoing professional discourse of latest on primary packaging technologies and business trends. This conference and the accompanying exhibition address quality of components and cont­ainers, container closure development and integrity testing as well as aspects of processing, product distribution and storage.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement